Tablet trialled at Liverpool's University Hospital Aintree could saves lung di... - The Diigo Meta page

• 14 Sep 09
  

  Kieran Lamb

  A DAILY tablet trialled at a Merseyside hospital could save the lives of millions of lung disease sufferers around the world.
  
  The pill, Roflumilast, tested by patients at University Hospital Aintree, treats one of the world’s biggest killers – chronic obstructive pulmonary disease (COPD), a term for chronic bronchitis and emphysema.

  Health News CMHN Drug Therapy COPD Respiratory Tract Diseases Liverpool Daily Post Lung Diseases

Would you like to comment?

Join Diigo for a free account, or sign in if you are already a member.